
1. malar j. 2020 may 27;19(1):193. doi: 10.1186/s12936-020-03259-9.

utility plasmodium falciparum dna rapid diagnostic test kits for
molecular analysis whole genome amplification.

srisutham s(1)(2), suwannasin k(2), mathema vb(3), sriprawat k(4), smithuis
fm(5)(6)(7), nosten f(4)(6), white nj(2)(6), dondorp am(2)(6), imwong
m(8)(9)(10).

author information: 
(1)department clinical microscopy, faculty allied health sciences,
chulalongkorn university, bangkok, thailand.
(2)mahidol-oxford tropical medicine research unit, faculty tropical medicine, 
mahidol university, bangkok, thailand.
(3)department molecular tropical medicine genetics, faculty tropical
medicine, mahidol university, bangkok, thailand.
(4)shoklo malaria research unit, faculty tropical medicine, mahidol
university, mae sot, thailand.
(5)myanmar oxford clinical research unit, yangon, myanmar.
(6)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk.
(7)medical action myanmar, yangon, myanmar.
(8)mahidol-oxford tropical medicine research unit, faculty tropical medicine, 
mahidol university, bangkok, thailand. noi@tropmedres.ac.
(9)department molecular tropical medicine genetics, faculty tropical
medicine, mahidol university, bangkok, thailand. noi@tropmedres.ac.
(10)centre tropical medicine global health, nuffield department of
medicine, university oxford, oxford, uk. noi@tropmedres.ac.

background: rapid diagnostic tests (rdts) become common diagnostic 
tool detection plasmodium falciparum malaria, particular remote
areas. rdt blood spots provide source parasite dna molecular analysis.
in study, utility rdts molecular analysis performance 
different methods whole genome amplification investigated.
methods: positive p. falciparum rdts collected kayin, myanmar from
august 2014 january 2016. the rdt samples stored 6 months, 9 months, 
20 months, 21 months, 32 months dna extraction subsequent
molecular analysis p. falciparum kelch 13 (pfkelch13) mutations, p. falciparum
multidrug resistance 1 (pfmdr1), p. falciparum plasmepsin 2 (pfplasmepsin2)
gene amplification. addition, performance four whole genome amplification
(wga) kits compared, including repli-g®, malbactm, picoplex®, and
genomeplex®, dna quantity quality compared original
dna post-wga products.
results: proportion successful amplification different molecular
markers similar blood spots analysed rdts stored 6, 9, 20,
21, 32 months. successful amplification dependent molecular markers
fragment length (p value < 0.05): 18% 1245 bp fragment pfkelch13, 71%
for 364 bp pfkelch13, 81% 87 bp pfmdr1, 81% 108 bp of
pfplasmepsin2. comparison four wga assay kits showed repli-g®,
malbactm, picoplex® increased quantity dna 60 750-fold, whereas the
ratio parasite dna amplification human dna favourable for
malbac®. sequencing results pfkelch13, p. falciparum chloroquine resistance
transporter (pfcrt), p. falciparum dihydrofolate reductase (pfdhfr) six
microsatellite markers assessed post-wga product from
the original dna.
conclusions: blood spots rdts good source molecular analysis p.
falciparum, even storage 32 months. wga rdt-derived parasite dna
reliably increase dna quantity sufficient quality molecular analysis 
resistance markers.

doi: 10.1186/s12936-020-03259-9 
pmcid: pmc7251736
pmid: 32460780 

